Literature DB >> 17167114

Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome.

Csaba P Kovesdy1, John E Anderson, Kamyar Kalantar-Zadeh.   

Abstract

High total cholesterol is associated with lower mortality in dialysis patients, but the relationship between lipid levels and mortality in patients who have chronic kidney disease (CKD) and are not yet on dialysis is poorly described. This study examined the association between lipid levels and all-cause and cardiovascular mortality in 986 male patients (age 67.4 +/- 10.9 yr; race 23.7% black) who had CKD and were not yet on dialysis. Associations were determined in fixed-covariate and time-dependent Cox models, before and after adjustment for components of case mix and surrogates for malnutrition-inflammation-cachexia syndrome (MICS). Lower total cholesterol quartiles were associated with higher all-cause mortality in a fixed-covariate model that was adjusted for age, race, and body mass index (hazard ratio [95% confidence interval] for cholesterol <153, 153 to 182, and 183 to 215 versus >215 mg/dl: 1.91 [1.35 to 2.69], 1.36 [0.96 to 1.92], 1.10 [0.78 to 1.57]; P < 0.001 for trend), but this association was attenuated after adjustment for case mix (P = 0.023 for trend) and abolished after additional adjustment for MICS (P = 0.14 for trend), with time-dependent Cox models showing similar results. Similar tendencies also were detected in the association between levels of LDL cholesterol with total and cardiovascular mortality and triglycerides with all-cause mortality in both fixed-covariate and time-dependent analyses. Lower lipid levels are associated with higher mortality in patients who have moderate and advanced CKD and are not yet on dialysis. This inverse association is explained in part by case-mix characteristics and the presence of surrogates for MICS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17167114     DOI: 10.1681/ASN.2006060674

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  51 in total

1.  The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis.

Authors:  Kamyar Kalantar-Zadeh; Elani Streja; Csaba P Kovesdy; Antigone Oreopoulos; Nazanin Noori; Jennie Jing; Allen R Nissenson; Mahesh Krishnan; Joel D Kopple; Rajnish Mehrotra; Stefan D Anker
Journal:  Mayo Clin Proc       Date:  2010-11       Impact factor: 7.616

2.  Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis.

Authors:  Winfried März; Bernd Genser; Christiane Drechsler; Vera Krane; Tanja B Grammer; Eberhard Ritz; Tatjana Stojakovic; Hubert Scharnagl; Karl Winkler; Ingar Holme; Hallvard Holdaas; Christoph Wanner
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 8.237

Review 3.  Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations.

Authors:  Heidi Noels; Michael Lehrke; Raymond Vanholder; Joachim Jankowski
Journal:  Nat Rev Nephrol       Date:  2021-05-10       Impact factor: 28.314

Review 4.  Negative trials in nephrology: what can we learn?

Authors:  James E Novak; Jula K Inrig; Uptal D Patel; Robert M Califf; Lynda A Szczech
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

5.  Association of serum lipids with outcomes in Hispanic hemodialysis patients of the West versus East Coasts of the United States.

Authors:  Hamid Moradi; Pouya Abhari; Elani Streja; Moti L Kashyap; Gaurang Shah; Daniel Gillen; Madeleine V Pahl; Nosratola D Vaziri; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2015-05-30       Impact factor: 3.754

6.  CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis.

Authors:  Julio A Lamprea-Montealegre; Brad C Astor; Robin L McClelland; Ian H de Boer; Gregory L Burke; Christopher T Sibley; Daniel O'Leary; A Richey Sharrett; Moyses Szklo
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 8.237

Review 7.  Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.

Authors:  Valentina Kon; Haichun Yang; Sergio Fazio
Journal:  Arch Med Res       Date:  2015-05-23       Impact factor: 2.235

Review 8.  Mechanisms of homocysteine-induced glomerular injury and sclerosis.

Authors:  Fan Yi; Pin-Lan Li
Journal:  Am J Nephrol       Date:  2007-11-07       Impact factor: 3.754

9.  Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis.

Authors:  Yun Li; Lihua Zhang; Yong Gu; Chuanming Hao; Tongying Zhu
Journal:  Perit Dial Int       Date:  2013-03-01       Impact factor: 1.756

Review 10.  Role of HDL dysfunction in end-stage renal disease: a double-edged sword.

Authors:  Hamid Moradi; Nosratola D Vaziri; Moti L Kashyap; Hamid M Said; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2013-05       Impact factor: 3.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.